What is Mayflower Bioscience?
Mayflower Bioscience, headquartered in St. Louis, MO, is a key player in the life sciences sector, specializing in innovative solutions for drug discovery, cell biology, and molecular biology. The company offers a comprehensive portfolio of high-quality products, including antibodies, bioassays, and COVID-19 testing kits, designed to empower researchers across the US and Canada. Their commitment to sourcing and delivering unique research tools highlights their dedication to accelerating scientific progress and development initiatives.
How much funding has Mayflower Bioscience raised?
Mayflower Bioscience has raised a total of $732K across 1 funding round:
Debt
$732K
Debt (2024): $732K with participation from St Louis Bank
Key Investors in Mayflower Bioscience
St Louis Bank
St Louis Bank is a financial institution likely providing debt financing or operational capital, supporting Mayflower Bioscience's growth and strategic objectives.
What's next for Mayflower Bioscience?
The recent major strategic investment signals a period of accelerated growth and expansion for Mayflower Bioscience. This capital infusion is expected to fuel further innovation in their product development pipeline and enhance their market reach within the drug discovery and biotechnology sectors. The company is well-positioned to leverage this financing to solidify its standing as a leading provider of essential research products and services.
See full Mayflower Bioscience company page
